MedPath

CRYSVITA 30 MG SOLUTION FOR INJECTION

Registration Number: MAL22126023ARZ

Approved
Approval ID

b81e54a89cd5cae5

Registration Number

MAL22126023ARZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

1 VialsAvailable
Package Size: 1 Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

BurosumabActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CRYSVITA 30 MG SOLUTION FOR INJECTION - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform